ArticleAntioxidants (Basel, Switzerland)2026
Empagliflozin Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis via SIRT3: Mechanisms and Therapeutic Implications.
Taoshan Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.